XML 39 R25.htm IDEA: XBRL DOCUMENT v3.20.4
STOCK-BASED COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2020
STOCK-BASED COMPENSATION PLANS  
Schedule of outstanding and exercisable number of options

    

Outstanding Number of Options

    

Exercisable Number of Options

(in thousands)

(in thousands)

Plan Category

 

  

 

  

2005 Stock Option Plan

 

299

 

299

Equity Compensation Plans not approved by  Shareholders

 

37

 

25

2017 Stock Option Plan

 

670

 

251

Total

 

1,006

$

575

Summary of fair value of stock options grants

    

2020

    

2019

 

Weighted average expected term

 

6.79 years

 

6.25 years

Weighted average volatility

 

117

%  

122

%

Weighted average risk-free interest rate

 

1.59

%  

2.30

%

Dividend yield

 

0

%  

0

%

Schedule of share based compensation expenses recorded in the consolidated statement of income

The following table summarizes stock-based compensation expenses recorded in the condensed consolidated statements of operations (in thousands):

For the Years Ended December 31, 

    

2020

    

2019

Cost of Revenue

$

37

$

21

Sales and marketing expense

 

424

 

205

General, and administrative

2,220

594

Total stock based compensation expense

2,681

820

Summary of stock option activity under the option plan

A combined summary of stock option activity for all plans for the years ended December 31, 2020 and 2019 is presented below:

Weighted

Weighted

Average

Aggregate

Number of 

Average

Remaining

Intrinsic

Shares

Strike

Contractual

Value

    

(in thousands)

    

Price

    

Life (Years)

    

(in thousands)

Outstanding at December 31, 2018

 

1,885

$

0.80

 

Granted

 

653

$

5.81

 

Exercised

 

(503)

$

0.44

 

Expired

(6)

$

1.00

Forfeited

 

(174)

$

2.64

 

Outstanding at December 31, 2019

 

1,855

$

2.48

6.42

$

10,032

Outstanding at December 31, 2019

 

1,855

$

2.48

Granted

 

14

$

10.15

 

Exercised

 

(622)

$

0.90

 

Forfeited

(241)

$

4.68

Outstanding at December 31, 2020

 

1,006

$

3.04

6.47

$

10,483

Exercisable at December 31, 2020

 

575

$

1.62

5.35

$

6,807

Summary of stock options outstanding under the plans

Outstanding

Weighted average

Number of

Remaining

Weighted Average

Options

Contractual

Weighted Average

Exercisable Number of

Remaining Exercisable

Exercisable

Range

    

(in thousands)

    

Life (years)

    

Strike Price

    

Options (in thousands)

    

Contractual Life (years)

    

Strike Price

$0 to $2.00

 

473

 

4.60

$

0.35

 

401

 

4.28

$

0.33

$2.01 to $4.00

 

270

 

7.66

$

3.05

 

116

 

7.43

$

2.87

$4.01 to $6.00

 

19

 

8.25

$

4.45

 

 

$

$6.01 to $8.00

200

8.56

$

7.87

50

8.56

$

7.87

$8.01 to $10.00

 

41

 

8.92

$

9.22

 

8

 

8.86

$

8.98

$10.01 to $12.00

3

9.04

$

10.60

$

 

1,006

 

6.47

$

3.04

 

575

 

5.35

$

1.62

Schedule of restricted stock award activity under all equity compensation plans

A summary of our unvested stock options as of December 31, 2020 and 2019 and related activity is presented below:

Non-vested 

Shares 

Weighted 

Under 

Average 

Option 

Grant Date 

    

(in thousands)

    

Fair Value

Non-vested at December 31, 2018

 

569

$

1.44

Granted

 

653

$

5.12

Vested

 

(169)

$

1.24

Forfeited

 

(163)

$

2.44

Non-vested at December 31, 2019

 

890

$

4.03

Non-vested at December 31, 2019

 

890

$

4.03

Granted

 

14

$

8.88

Vested

 

(251)

$

3.34

Forfeited

 

(222)

$

4.36

Non-vested at December 31, 2020

 

431

$

4.35

A summary of restricted stock award activity under the 2017 Stock Plan for the years ended December 2020 and 2019 are presented below:

Number of Shares 

 

Weighted Average

    

(in thousands)

    

Grant Date Fair Value

Outstanding at December 31, 2018

 

76

$

3.19

Granted

 

55

$

8.10

Vested

 

(29)

$

3.24

Outstanding at December 31, 2019

 

102

$

5.81

Outstanding at December 31, 2019

 

102

$

5.81

Granted

 

320

$

12.92

Vested

 

(154)

$

8.54

Outstanding at December 31, 2020

 

268

$

12.64